Abstract
We report a case of Goldenhar syndrome and hereditary tyrosinemia type 1 (HTT1), to our knowledge an association not previously described. This case further increases the diversity of observations and clinical descriptions of patients with this complex syndrome. We discuss pathogenetic aspects, and demonstrate further evidence of the effectiveness of 2-(2-nitro-4-trifluoromethyl benzoyl)-1,3-cyclohexanedione in the treatment of HTT1.
Article Type
Case Report
First Page
55
Last Page
59
Recommended Citation
Al-Sayed, Moeen A.; Al-Asmari, Ali M.; and Rashed, Mohammed S.
(2003)
"Goldenhar syndrome and hereditary tyrosinemia type 1,"
Neurosciences: Vol. 8:
Iss.
1, Article 14.
DOI: https://doi.org/10.17712/1658-3183.1193